Professional Statements and Societal Positions Guidelines
National Institute for Health and Care Excellence-2018
The National Institute for Health and Care Excellence (NICE) updated their guidelines on chronic heart failure management and did not include outpatient hemodynamic monitoring as a recommendation.
In 2013, the Institute issued guidance on the insertion and use of implantable pulmonary artery pressure monitors in chronic heart failure. The recommendations concluded that 'Current evidence on the safety and efficacy of the insertion and use of implantable pulmonary artery pressure monitors in chronic heart failure is limited in both quality and quantity.'
Heart Failure Society of America-2018
The Heart Failure Society of America Scientific Statements Committee (2018) published a white paper consensus statement on remote monitoring of individuals with heart failure.
The committee concluded that: 'Based on available evidence, routine use of external RPM devices is not recommended. Implanted devices that monitor pulmonary arterial pressure and/or other parameters may be beneficial in selected individuals or when used in structured programs, but the value of these devices in routine care requires further study.'
American College of Cardiology et al-2017
The American College of Cardiology, the American Heart Association, and the Heart Failure Society of America issued joint guidelines on the management of heart failure that offered no recommendations for the use of ambulatory monitoring devices.
